Holen Sie sich die Stockscreener-App
7.59
2.57%
-0.20
Vorhandelsmarkt:
7.60
0.010
+0.13%
Arvinas Inc Aktie (ARVN) Neueste Nachrichten
Form 144 ARVINAS For: 27 September By Investing.com - Investing.com Australia
ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff - Stocktwits
Arvinas Q2 2026 Earnings Call Transcript - Benzinga
Arvinas (NASDAQ: ARVN) director plans stock sale under SEC resale rule - Stock Titan
ARVN Q2 2026 Earnings: EPS Swings to $2.58, Beating Estimates by a Wide MarginEarnings Outlook Update - dars.gov.et
Arvinas, Inc. (ARVN) Stock Analysis: Uncovering a Potential 67.61% Upside in the Biotech Sector - DirectorsTalk Interviews
Arvinas, Inc. $ARVN Shares Purchased by Squarepoint Ops LLC - MarketBeat
Piper Sandler Maintains Arvinas(ARVN.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Arvinas, Inc. (NASDAQ:ARVN) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Arvinas at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline takes center stage - investing.com
ARVN Stock Jumps 10% After FDA Approves Breast Cancer Drug A Month Ahead Of Schedule - Stocktwits
Former Arvinas (NASDAQ: ARVN) officer plans new stock sale - Stock Titan
(ARVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Arvinas (ARVN) Just Made Protein Degrader History With FDA Nod - Yahoo Finance
Arvinas at Wells Fargo conference: pipeline nears key data By Investing.com - Investing.com South Africa
Arvinas (ARVN) Stock Price, News & Analysis - Stock Titan
ARVN News | ARVINAS INC (NASDAQ:ARVN) - ChartMill
Former Arvinas (NASDAQ: ARVN) officer lines up new stock sale after recent trades - Stock Titan
Arvinas to Participate in Upcoming Investor Conferences - Yahoo Finance
Arvinas Inc. (ARVN) Key Financial Ratios – Valuation, Profitability & More - Value Research
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Arvinas Inc. (ARVN) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
ARVN Q2 2026 Earnings: EPS of $2.58 Blows Past Consensus; Stock Slips 0.65%Tax Rate Impact - vinanet.vn
The Technical Signals Behind (ARVN) That Institutions Follow - Stock Traders Daily
Arvinas: Veppanu Approval Underlines Degrader Platform PromiseI'm Bullish (NASDAQ:ARVN) - Seeking Alpha
Arvinas (ARVN) Momentum: Gains 3.77% to Reach $9.37 in the Current Update; Chart Watch - dars.gov.et
Arvinas (ARVN) Quarterly Results: EPS Lands Above Forecast for the Current Session; Trading Response: Shares Finish 4.54% Higher at the ClosePerformance Review - vinanet.vn
Arvinas, Inc. (NASDAQ:ARVN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Arvinas (ARVN) Q2 2026 Filing Snapshot: Reported EPS Tops Expectations at the Close; Price Reaction: Shares Move 0.22% Up in the Current UpdateEPS Growth Report - dars.gov.et
142,214 Shares in Arvinas, Inc. $ARVN Purchased by GSA Capital Partners LLP - MarketBeat
Arvinas Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Arvinas (ARVN) Holds Ground Near $8.97 as Biotech Stock Tests Key Support ZoneConversion Trade - vinanet.vn
Arvinas Inc (ARVN) Stock Price, Quote, News & History - Benzinga
D. E. Shaw adjusts Arvinas (ARVN) stake as one entity falls below 5% - Stock Titan
Arvinas (ARVN) Q2 2026 Earnings Call Transcript - AOL.com
Morgan Stanley Maintains Arvinas(ARVN.US) With Hold Rating, Maintains Target Price $10 - Moomoo
Enterprise value to EBITDA forward of Arvinas, Inc. – NASDAQ:ARVN - TradingView
ARVN Maintains by Evercore ISI Group -- Price Target Lowered to $14.00 - GuruFocus
ARVN Maintained by Citigroup -- Price Target Lowered to $21.00 - GuruFocus
A Quick Look at Today's Ratings for Arvinas(ARVN.US), With a Forecast Between $10 to $21 - Moomoo
Arvinas, Inc. Stock 12‑Month Price Target Cut to $13.93, Implies 59% Upside - TradingView
Morgan Stanley Adjusts Price Target on Arvinas to $10 From $11, Maintains Equalweight Rating - Yahoo Finance
Precision Trading with Arvinas Inc. (ARVN) Risk Zones - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), 10x Genomics (TXG) and Teleflex (TFX) - The Globe and Mail
Arvinas (NASDAQ:ARVN) Rating Increased to Hold at Wall Street Zen - MarketBeat
Arvinas Inc (ARVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BofA Securities Maintains Arvinas(ARVN.US) With Hold Rating - Moomoo
Enterprise value to EBIT forward of Arvinas, Inc. – NASDAQ:ARVN - TradingView
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):